Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Dow
US Army
Chubb
Boehringer Ingelheim
Argus Health
Cerilliant
US Department of Justice
Express Scripts

Generated: June 25, 2018

DrugPatentWatch Database Preview

SPECTRACEF Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

When do Spectracef patents expire, and when can generic versions of Spectracef launch?

Spectracef is a drug marketed by Vansen Pharma and is included in one NDA.

The generic ingredient in SPECTRACEF is cefditoren pivoxil. There are six drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the cefditoren pivoxil profile page.
Summary for SPECTRACEF
US Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: 2
Bulk Api Vendors: 33
Patent Applications: 568
DailyMed Link:SPECTRACEF at DailyMed
Drug patent expirations by year for SPECTRACEF
Pharmacology for SPECTRACEF
Synonyms for SPECTRACEF
(-)-(6R,7R)-2,2-dimethylpropionyloxymethyl 7-((Z)-2-(2-aminothiazol-4-yl)-2-methoxyiminoacetamido)-3-((Z)-2-(4-methylthiazol-5-yl)ethenyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate
(pivaloyloxy)methyl (6R,7R)-7-((Z)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-3-((Z)-2-(4-methylthiazol-5-yl)vinyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
[(2,2-dimethylpropanoyl)oxy]methyl (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-[(Z)-2-(4-methyl-1,3-thiazol-5-yl)ethenyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
[(2,2-dimethylpropanoyl)oxy]methyl 7beta-(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetamido-3-[(Z)-2-(4-methyl-1,3-thiazol-5-yl)ethenyl]-3,4-didehydrocepham-4-carboxylic acid
117467-28-4
2,2-dimethylpropanoyloxymethyl (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(Z)-2-(4-methyl-1,3-thiazol-5-yl)ethenyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
2,2-dimethylpropanoyloxymethyl (6R,7R)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-methoxyimino-acetyl]amino]-3-[(Z)-2-(4-methylthiazol-5-yl)vinyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
467C284
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-3-((1Z)-2-(4-methyl-5-thiazolyl)ethenyl)-8-oxo-,2,2-dimethyl-1-oxopropoxy)methyl ester, (6R,7R)-
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-3-(2-(4-methyl-5-thiazolyl)ethenyl)-8-oxo-, (2,2-dimethyl-1-oxopropoxy)methyl ester, (6R-(3(Z),6-alpha,7-beta-(Z)))-
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-3-(2-(4-methyl-5-thiazolyl)ethenyl)-8-oxo-, (2,2-dimethyl-1-oxopropoxy)methyl ester, (6R-(3(Z),6alpha,7beta(Z)))-
7-(2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-3-(2-(4-methylthiazol-5-yl)ethenyl)cephem-4-carboxylic acid pivaloyloxymethyl ester
78THA212DH
AB01274730_02
AB01274730-01
AB2000281
AC1O5OKO
AKOS025311444
AN-10902
AS-12951
AT-20809
B2086
C25H28N6O7S3
CAS-117467-28-4
CCRIS 7768
CDTR-PI
Cefditoren (pivoxil)
Cefditoren PI voxil
Cefditoren pivaloyloxymethyl ester
cefditoren pivoxil
Cefditoren pivoxil (JP17)
Cefditoren Pivoxil [JAN]
Cefditoren pivoxil [USAN:JAN]
cefditoren pivoxyl
cefditoren-pivoxil
Cefditorin
CEFDITORIN PIVOXIL
CHEBI:560555
CHEMBL454446
CS-1949
D01628
DSSTox_CID_28669
DSSTox_GSID_48743
DSSTox_RID_82939
DTXSID2048743
HY-17452A
LS-150028
ME 1207
ME-1207
ME1207
Meiact
MolPort-006-167-698
NCGC00095175-01
pivaloyloxymethyl (+)-(6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-[(Z)-2-(4-methyl-1,3-thiazol-5-yl)ethenyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
PubChem21340
s1768
SCHEMBL182876
Spectracef ;Meiact
Tox21_113197
UNII-78THA212DH

US Patents and Regulatory Information for SPECTRACEF

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Vansen Pharma SPECTRACEF cefditoren pivoxil TABLET;ORAL 021222-001 Aug 29, 2001 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Vansen Pharma SPECTRACEF cefditoren pivoxil TABLET;ORAL 021222-002 Jul 21, 2008 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for SPECTRACEF

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Vansen Pharma SPECTRACEF cefditoren pivoxil TABLET;ORAL 021222-002 Jul 21, 2008 ➤ Sign Up ➤ Sign Up
Vansen Pharma SPECTRACEF cefditoren pivoxil TABLET;ORAL 021222-001 Aug 29, 2001 ➤ Sign Up ➤ Sign Up
Vansen Pharma SPECTRACEF cefditoren pivoxil TABLET;ORAL 021222-001 Aug 29, 2001 ➤ Sign Up ➤ Sign Up
Vansen Pharma SPECTRACEF cefditoren pivoxil TABLET;ORAL 021222-002 Jul 21, 2008 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Chinese Patent Office
Covington
Daiichi Sankyo
US Department of Justice
Harvard Business School
Fuji
Merck
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.